Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial for the Treatment of Advanced Classical Kaposi's Sarcoma With the HIV Protease Inhibitor Indinavir in Combination With Chemotherapy

NCT01067690 is registered in ClinicalTrials.gov with Barbara Ensoli, MD, PhD as lead sponsor.

NCT NCT01067690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01067690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial for the Treatment of Advanced Classical Kaposi's Sarcoma With the HIV Protease Inhibitor Indinavir in Combination With Chemotherapy
Lead sponsor
Barbara Ensoli, MD, PhD
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2008
Completion date
June 30, 2016
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kaposi's sarcoma